School personnel information

写真b

MAEDA Makiko


Keyword

Clinical Pharmacology, Clinical Pharmacy, Clinical Study

Mail Address

Mail Address

Laboratory Phone number

+81-6-6879-8163

Laboratory Fax number

+81-6879-8253

Gender

Female

Organization 【 display / non-display

  • 2005.04.01 - 2005.07.31, Applied Biopharamaceutical Sciences, Graduate School of Pharmaceutical Sciences, Specially Appointed Researcher

  • 2007.04.01 - 2012.03.31, Applied Biopharamaceutical Sciences, Graduate School of Pharmaceutical Sciences, Visiting Academic Staff

  • 2013.06.01 - 2015.03.31, Center for Advanced Eduction and Research in Pharmaceutical Sciences, Graduate School of Pharmaceutical Sciences, Associate Professor

  • 2017.04.01 - , Center for Advanced Eduction and Research in Pharmaceutical Sciences, Graduate School of Pharmaceutical Sciences, Associate Professor

Education 【 display / non-display

Osaka University Graduate School, Division of Pharmaceutical Sciences  Completed 2005.03

Academic Society Membership 【 display / non-display

  • American Heart Association

 

Academic Papers 【 display / non-display

  • Verification of pharmacogenomics-based algorithms to predict warfarin maintenance dose using registered data of Japanese patients. , Sasano M, Ohno M, Fukuda Y, Nonen S, Hirobe S, Maeda S, Miwa Y, Yokoyama J, Nakayama H, Miyagawa S, Sawa Y, Fujio Y, Maeda M.,Eur J Clin Pharmacol. , 2019.03, Papers

  • Blockade of NKG2D/NKG2D ligand interaction attenuated cardiac remodeling after myocardial infarction., Matsumoto, K., Obana, M., Kobayashi, A., Miyagawa, S., Maeda, M., Sakata, Y., Nakayama, H., Sawa, Y., Fujio, Y. , Cardiovasc. Res. ,115(4) 765-775, 2019.03, Papers

  • Myofibroblast β2 adrenergic signaling amplifies cardiac hypertrophy in mice., Imaeda A, Tanaka S, Tonegawa K, Fuchigami S, Obana M, Maeda M, Kihara M, Kiyonari H, Conway SJ, Fujio Y, Nakayama H., Biochemical and Biophysical Research Communications,510(1) 149-155, 2019.02, Papers

  • Eukaryotic translation initiation factor 3 subunit C is associated with acquired resistance to erlotinib in non-small cell lung cancer., Shintani T, Higashisaka K, Maeda M, Hamada M, Tsuji R, Kurihara K, Kashiwagi Y, Sato A, Obana M, Yamamoto A, Kawasaki K, Lin Y, Kijima T, Kinehara Y, Miwa Y, Maeda S, Morii E, Kumanogoh A, Tsutsumi Y, Nagatomo I, Fujio Y., Oncotarget,9(101) 37520-37533, 2018.12, Papers

  • 2-aminoethoxydiphenyl borate provides an anti-oxidative effect and mediates cardioprotection during ischemia reperfusion in mice., Morihara H, Obana M, Tanaka S, Kawakatsu I, Tsuchiyama D, Mori S, Suizu H, Ishida A, Kimura R, Tsuchimochi I, Maeda M, Yoshimitsu T, Fujio Y, Nakayama H., PLoS One,12(12):e0189948., 2017.12, Papers

display all >>